Preston Klassen
2012 - Orexigen Therapeutics
In 2012, Preston Klassen earned a total compensation of $1.3M as Head of Global Contrave Program and Executive Vice President, Product Development at Orexigen Therapeutics, a 41% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $240,500 |
---|---|
Option Awards | $655,795 |
Salary | $370,000 |
Other | $120 |
Total | $1,266,415 |
Klassen received $655.8K in option awards, accounting for 52% of the total pay in 2012.
Klassen also received $240.5K in non-equity incentive plan, $370K in salary and $120 in other compensation.
Rankings
In 2012, Preston Klassen's compensation ranked 5,206th out of 11,487 executives tracked by ExecPay. In other words, Klassen earned more than 54.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,206 | 55th |
Manufacturing | 1,819 | 57th |
Chemicals And Allied Products | 436 | 64th |
Drugs | 285 | 69th |
Pharmaceutical Preparations | 224 | 68th |
Klassen's colleagues
We found four more compensation records of executives who worked with Preston Klassen at Orexigen Therapeutics in 2012.